Claudia Allemani
A5107970561- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Economic and Financial Impacts of Cancer
- Multiple and Secondary Primary Cancers
- Cancer Risks and Factors
- Glioma Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
- Genetic factors in colorectal cancer
- Childhood Cancer Survivors' Quality of Life
- Breast Cancer Treatment Studies
- Lymphoma Diagnosis and Treatment
- Ovarian cancer diagnosis and treatment
- Global Public Health Policies and Epidemiology
- Advances in Oncology and Radiotherapy
- Acute Myeloid Leukemia Research
- Lung Cancer Treatments and Mutations
- Cutaneous Melanoma Detection and Management
- Radiomics and Machine Learning in Medical Imaging
- Health Systems, Economic Evaluations, Quality of Life
- Colorectal Cancer Surgical Treatments
- BRCA gene mutations in cancer
- COVID-19 and healthcare impacts
- Endometrial and Cervical Cancer Treatments
- Cervical Cancer and HPV Research
- Chronic Lymphocytic Leukemia Research
London School of Hygiene & Tropical Medicine
2016-2025
University of London
2013-2023
London Cancer
2017-2022
Fondazione IRCCS Istituto Nazionale dei Tumori
2007-2022
University of Manchester
2021
Laboratoire de Biométrie et Biologie Evolutive
2017
Cancer Research UK
2012-2016
Institut Català d'Oncologia
2015
Government of Catalonia
2015
National Institutes of Health
2015
Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of by central analysis population-based registry data, as a metric the effectiveness health systems, and inform global policy on control.
Global inequalities in access to health care are reflected differences cancer survival. The CONCORD programme was designed assess worldwide and trends population-based In this study, we aimed estimate survival globally for several subtypes of childhood leukaemia. Cancer registries participating were asked submit tumour registrations all children aged 0-14 years who diagnosed with leukaemia between Jan 1, 1995, Dec 31, 2009, followed up until 2009. Haematological malignancies defined by...
Survival from metastatic cutaneous melanoma is substantially lower than for localized disease. Treatments have been limited, but remarkable clinical improvements reported in trials the last decade. We described characteristics of US patients diagnosed with during 2001-2013 and assessed trends short-term survival distant-stage disease.Trends 1-year net were estimated using Pohar Perme estimator, controlling background mortality life tables all-cause rates by county residence, single year age,...
Abstract Background CONCORD-3 highlighted wide disparities in population-based 5-year net survival for cutaneous melanoma during 2000–2014. Clinical evidence suggests marked international differences the proportion of lethal acral and nodular subtypes melanoma. Objectives We aimed to assess whether morphology may explain global variation survival. Methods Patients with were grouped into following seven morphological categories: malignant melanoma, not otherwise specified (International...
Objectives To estimate occupational differences in COVID-19 mortality and test whether these are confounded by factors such as regional differences, ethnicity education or due to non-workplace factors, deprivation prepandemic health. Methods Using a cohort study of over 14 million people aged 40–64 years living England, we analysed death involving COVID-19, assessed between 24 January 2020 28 December 2020. We estimated age-standardised rates (ASMRs) per 100 000 person-years at risk...
We used multiple regression models to assess the influence of disease stage at diagnosis on 5-year relative survival 4,478 patients diagnosed with breast cancer in 1990-1992. The cases were representative samples from 17 population-based registries 6 European countries (Estonia, France, Italy, Netherlands, Spain and UK) that combined into 9 regional groups based similar survival. Five-year was 79% overall, varying 98% for early, node-negative (T1N0M0) tumours; 87% large, (T2-3N0M0) 76%...
Abstract BACKGROUND Breast carcinoma survival rates were found to be higher in the U.S. than Europe. METHODS Multiple regression analysis of breast among women diagnosed between 1990 and 1992 was performed using clinical data from population‐based case series Surveillance, Epidemiogy, End Results (SEER) program (13,172 women) European Concerted Action on Care Cancer Patients (EUROCARE) project (4478 women). RESULTS Early‐stage tumors (T1N0M0) more frequent SEER (41% cases) EUROCARE (29%). In...
BACKGROUND In the first CONCORD study (2008), 5‐year survival for patients diagnosed with colon cancer between 1990 and 1994 in United States was among highest world (60%), but there were large racial disparities most participating states. The CONCORD‐2 (2015) enabled examination of trends 1995 2009 US states by race stage. METHODS authors analyzed data from 37 state population‐based registries, covering approximately 80% population, who 2001 followed through 2009. Survival up to 5 years...
Breast cancer survival is reportedly higher in the US than Europe. The first worldwide study (CONCORD) found wide international differences age-standardized survival. aim of this to explain these differences. Population-based data on stage at diagnosis, diagnostic procedures, treatment and follow-up were collected for about 20,000 women diagnosed with breast aged 15-99 years during 1996-98 7 states 12 European countries. Age-standardized net excess hazard death up 5 after diagnosis estimated...
We provide an up-to-date international comparison of cancer survival, assessing whether England is 'closing the gap' compared with other high-income countries.
Overall, cervical cancer survival in the United States has been reported to be among highest world, despite slight decreases over last decade. Objective of current study was describe trends US women and examine differences by race stage.This used data from CONCORD-2 compare (aged 15-99 years) diagnosed 37 states covering 80% population. Survival adjusted for background mortality (net survival) with state- race-specific life tables age-standardized International Cancer Standard weights....